A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease

1991818 citationsJournal Articlebronze Open Access

Authors

The International Chronic Granulomatous Disease Cooperative Study Group* · TiGenix (Spain)

Abstract

For patients with chronic granulomatous disease, interferon gamma therapy is an effective and well-tolerated treatment that reduces the frequency of serious infections.

Topics & Keywords

Neutrophil, Myeloperoxidase and Oxidative Mechanisms Inflammasome and immune disorders Immune Response and Inflammation

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 324, Issue 8, pp. 509-516

DOI: 10.1056/nejm199102213240801

Field-Weighted Citation Impact: 15.94